Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Through life experiences and relationships, it’s hard not to cross paths with people who’ve been impacted by the opioid crisis. Maybe they themselves dealt with opioid abuse or perhaps have ...

Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

The unprecedented increase in drug overdose deaths in the U.S., long believed to be driven by access to legal and illegal ...

Purdue Pharma and its Sackler family owners have reached a new opioid settlement to resolve thousands of lawsuits.

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...

The agreement also ends the Sacklers’ control of Purdue Pharma and prohibits them from selling opioids in the United States.